5081 - 5090 of 8587 Results
Title
Year
- Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 42018OPENTitle: Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4Journal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-018-1337-8Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-018-1337-8Citation Count: 42
- Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s Disease2023OPENTitle: Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 17Start Page: 13435End Page: 13435Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms241713435Best OA location URL: https://www.mdpi.com/1422-0067/24/17/13435/pdf?version=1693464631Citation Count: 4
-
OPENTitle: Importance of low diagnostic Accuracy for early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1551End Page: 1554Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27485Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6544441Citation Count: 109
-
RESTRICTEDTitle: Transdermal Nicotine Treatment and Progression of Early Parkinson’s DiseaseJournal Name: NEJM EvidencePublisher: Massachusetts Medical SocietyVol: 2Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1056/evidoa2200311Citation Count: 16
-
OPENTitle: Disease progression models for dominantly-inherited Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 5Start Page: 1244End Page: 1246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awy089Best OA location URL: https://academic.oup.com/brain/article-pdf/141/5/1244/25083196/awy089.pdfCitation Count: 2
-
OPENTitle: Mutant Allele-Specific CRISPR Disruption in DYT1 Dystonia Fibroblasts Restores Cell FunctionJournal Name: Molecular Therapy Nucleic AcidsPublisher: Elsevier BVVol: 21Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2020.05.009Best OA location URL: http://www.cell.com/article/S2162253120301359/pdfCitation Count: 11
-
OPENTitle: Mitochondrial therapies for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22781Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5797696Citation Count: 58
- Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity2019OPENTitle: Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicityJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 6Start Page: 939End Page: 960Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-019-01993-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-019-01993-2.pdfCitation Count: 76
-
OPENTitle: The End Is the Beginning: Parkinson’s Disease in the Light of Brain ImagingJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2017.00330Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2017.00330/pdfCitation Count: 34
- Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)2018RESTRICTEDTitle: Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p3.048Citation Count: 4